Clinical Trials Browser

Recruiting × Interventional × Esthesioneuroblastoma, Olfactory × Clear all

Medulloblastoma, Meningioma, Paraganglioma, Pituitary Neoplasms, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory, Hemangioblastoma

NCT06176989 2025-10-20

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

Phase 2 Recruiting

40 enrolled

CNSSarcoma

Sinonasal undifferentiated carcinoma, Chondrosarcoma, Esthesioneuroblastoma, Olfactory

NCT06814496 2025-10-09

RABBIT

Phase 1/2 Recruiting

30 enrolled

CNSDermatologicGenitourinaryGynecologicThoracic

Sinonasal undifferentiated carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Glioblastoma, Melanoma, Testicular Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory

NCT06255210 2024-02-13

ESICON

Phase 2 Recruiting

25 enrolled

CNS

Esthesioneuroblastoma, Olfactory

Clinical Trials

DOMINO-START

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

RABBIT

ESICON